Federal contract award

75N95019C00042

TITLE: ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. POP AUGUST 4, 2019 - AUGUST 3, 2020.

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTES OF HEALTH NIDA
NAICS541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSCAN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeCOST PLUS FIXED FEE
Obligations$3.3M
Current contract value$3.3M
Potential contract value / ceiling$3.3M
Start dateAug 4, 2019
Current end dateAug 3, 2024
Potential end dateAug 3, 2024
Latest award activityJul 20, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 11 of 11 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jul 20, 2026P00010$-31.4KDEOBLIGATION. ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. N01DA-19-8950. PERIOD OF PERFORMANCE: AUGUST 4, 2019 - AUGUST 3, 2024.
Mar 13, 2026P00009$0ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. N01DA-19-8950. PERIOD OF PERFORMANCE: AUGUST 4, 2019 - AUGUST 3, 2024.
Jul 1, 2024P00008$-100.6KDEOBLIGATE FY19 FUNDS. ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. N01DA-19-8950. PERIOD OF PERFORMANCE: AUGUST 4, 2019 - AUGUST 3, 2024.
Jul 25, 2023P00007$714.5KANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. N01DA-19-8950. PERIOD OF PERFORMANCE: AUGUST 4, 2019 - AUGUST 3, 2024.
Aug 3, 2022P00005$0TITLE: ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. N01DA-19-8950. PERIOD OF PERFORMANCE: AUGUST 4, 2019 - AUGUST 3, 2022.
Aug 3, 2022P00006$696.4KTITLE: ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. N01DA-19-8950. PERIOD OF PERFORMANCE: AUGUST 4, 2019 - AUGUST 3, 2023.
Aug 2, 2021P00004$678.8KTITLE: ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. N01DA-19-8950. PERIOD OF PERFORMANCE: AUGUST 4, 2019 - AUGUST 3, 2022.
Apr 6, 2021P00003$0TITLE: ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. N01DA-19-8950. BASE PERIOD: POP AUGUST 4, 2019 - AUGUST 3, 2021.
Jan 4, 2021P00002$0TITLE: ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. N01DA-19-8950. BASE PERIOD: POP AUGUST 4, 2019 - AUGUST 3, 2021.
Jun 26, 2020P00001$661.7KTITLE: ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. N01DA-19-8950. BASE PERIOD: POP AUGUST 4, 2019 - AUGUST 3, 2020. THE PURPOSE OF THIS MODIFICATION IS TO EXERCISE OPTION PERIOD 1: AUGUST 4, 2020 - AUG
Aug 2, 20190$645.2KTITLE: ANALYTICAL CHEMISTRY AND STABILITY TESTING OF TREATMENT DRUGS FOR SUBSTANCE USE DISORDERS. POP AUGUST 4, 2019 - AUGUST 3, 2020.

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.